{
    "organizations": [],
    "uuid": "548d7584cd92b6b79024d63f8a6f5696e84fcf1f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cleveland-biolabs-reports-quarterl/brief-cleveland-biolabs-reports-quarterly-loss-per-share-of-0-11-idUSFWN1SM10H",
    "ord_in_thread": 0,
    "title": "BRIEF-Cleveland Biolabs Reports Quarterly Loss Per Share Of $0.11",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Cleveland Biolabs Inc:\n* CLEVELAND BIOLABS INC - REVENUE FOR Q1 OF 2018 DECREASED TO $0.2 MILLION COMPARED TO $0.6 MILLION FOR Q1 OF 2017\n* CLEVELAND BIOLABS INC QTRLY LOSS PER SHARE $0.11 Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T20:14:00.000+03:00",
    "crawled": "2018-05-16T19:18:10.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cleveland",
        "biolabs",
        "inc",
        "cleveland",
        "biolabs",
        "inc",
        "revenue",
        "q1",
        "decreased",
        "million",
        "compared",
        "million",
        "q1",
        "cleveland",
        "biolabs",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}